HIV Treatment Recent News
Long-Acting HIV Treatment Backed By GSK, Pfizer Scores FDA Approval As Preventative Option
Merck Stops Enrollment In Two Islatravir Trials For Prevention Of HIV Infection
Gilead, Merck Stop Enrollment In Mid-Stage HIV Combination Therapy Trial
Merck Pauses Development Of MK-8507 In HIV Infection
ViiV Healthcare's Dovato Combo Regime Shows Encouraging Long Term Data In HIV Patients
ViiV In-Licenses Third-Gen HIV Targeting Compound From Shionogi
GSK, Pfizer Backed Long-Acting HIV Med Under FDA Priority Review As Preventative Option
GSK- Pfizer's ViiV To Develop 'Ultra-Long-Acting' HIV Drugs With $215M Halozyme Deal
Gilead, Merck Team Up To Develop Long-Acting HIV Infection Treatments
Pfizer, GSK-Backed ViiV First To Get FDA Approval For Injectable Drug To Treat HIV
Helping Patients More With Less Drugs: An Interview With CytoDyn's CEO